Literature DB >> 7548116

Phospholipase A2-induced stimulation of A549 lung adenocarcinoma cell line proliferation.

H Tokumoto1, J D Croxtall, Q Choudhury, R J Flower.   

Abstract

Phospholipase A2 (PLA2) activity was found in the cytosolic fraction of the A549 human lung adenocarcinoma line. This PLA2 had a molecular mass of approximately 70 kDa as assessed by gel filtration chromatography and required submicromolar concentrations of calcium concentrations for optimal activity. These characteristics are consistent with the cytosolic PLA2 recently reported in other cell types, such as U937 cells. We have now demonstrated that A549 cell PLA2 (PLA2 activity: 1 unit/ml) partially purified by gel filtration stimulated proliferation of A549 cells by 50% after 3 days of culture. Similarly, porcine pancreatic PLA2 (0.1 unit/ml) also promoted proliferation of A549 cell cultures by 42%. Furthermore, A549 cell PLA2 stimulated prostaglandin E2 release (approx. 7-fold increase). Both PLA2s lost activity when treated with p-bromophenacyl bromide. Neither porcine pancreatic PLA2 nor A549 cell PLA2 reversed the inhibitory activities of dexamethasone and indomethacin on cell growth. These results suggest that both of these PLA2s stimulate A549 cell growth, and that this is likely to be mediated by increased eicosanoid production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7548116     DOI: 10.1016/0005-2760(93)90246-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Investigation into the involvement of phospholipases A(2) and MAP kinases in modulation of AA release and cell growth in A549 cells.

Authors:  Q G Choudhury; D T McKay; R J Flower; J D Croxtall
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma.

Authors:  Minna Helin; Seppo Rönkkö; Tuomo Puustjärvi; Markku Teräsvirta; Hannu Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-15       Impact factor: 3.117

3.  Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.

Authors:  Reza Ehsanian; Carter Van Waes; Stephan M Feller
Journal:  Cell Commun Signal       Date:  2011-05-15       Impact factor: 5.712

4.  Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine.

Authors:  P L de Souza; M Castillo; C E Myers
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  The Effect of a Unique Region of Parvovirus B19 Capsid Protein VP1 on Endothelial Cells.

Authors:  Ieva Rinkūnaitė; Egidijus Šimoliūnas; Daiva Bironaitė; Rasa Rutkienė; Virginija Bukelskienė; Rolandas Meškys; Julius Bogomolovas
Journal:  Biomolecules       Date:  2021-04-19

6.  Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.

Authors:  Seppo Rönkkö; Petri Rekonen; Kai Kaarniranta; Tuomo Puustjarvi; Markku Teräsvirta; Hannu Uusitalo
Journal:  Mol Vis       Date:  2007-03-26       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.